Tradestie Institutional Equity Comparison Engine

TVTX vs PVLA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PVLA Overall Edge

PVLA Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TVTX counters with relative strength in Valuation. Fundamentally, TVTX trades at 9.3x Forward P/E with -3.1% operating margin (+36.2% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, TVTX sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TVTX
TVTX 9.3x vs PVLA N/M Fwd P/E
Growth & Margin Winner PVLA
Op Margin -3.1% vs 0.0% ยท YoY +36.2% vs +0.0%
Momentum & Technical Winner PVLA
1Y +47.2% vs +80.2% ยท 52W Pos 59% vs 68%
Options & Structure Winner PVLA
CONSOLIDATION (6th %ile IV) vs CONSOLIDATION (2nd %ile IV)
TVTX NASDAQ
Travere Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$49.90
-1.48% 1D
Market Cap $4.9B
1M Return +0.6%
1Y Return +47.24%
Forward P/E 9.3x
Unified AI Score
60.2 / 100 BUY
Tech 47.0 Fund 57.0 Flow 64.0 Mom 64.0
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap $2.2B
1M Return +20.56%
1Y Return +80.16%
Forward P/E N/M
Unified AI Score
48.9 / 100 HOLD
Tech 38.0 Fund 52.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TVTX +47.24% PVLA +80.16% Spread: +32.92 pp (PVLA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period TVTX Revenue PVLA Revenue TVTX Op. Margin PVLA Op. Margin Margin Edge
FY2018 $160M $30M -48.7% -113.1% TVTX
FY2019 $180M $40M -78.3% -62.2% PVLA
FY2020 $200M $30M -88.8% -115.7% TVTX
FY2021 $130M $30M -151.3% -165.0% TVTX
FY2022 $110M $30M -292.2% -167.8% PVLA
FY2023 $150M $40M -267.2% -27.7% PVLA
FY2024 $230M N/A -138.9% N/A TVTX
FY2025 $490M N/A -12.8% N/A TVTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TVTX (6) vs PVLA (4)
Institutional Metric TVTX PVLA Criterion Row Winner
Market Capitalization Scale $4.9B $2.2B Larger Scale TVTX
Trailing P/E Ratio Valuation 25.8x N/M Lower Multiple TVTX
Forward P/E Ratio Valuation 9.3x N/M Lower Multiple TVTX
Revenue Growth (YoY) Growth +36.2% +0.0% Higher Growth TVTX
Operating Margin (TTM) Profitability -3.1% 0.0% Higher Margin PVLA
Net Profit Margin Profitability -18.7% 0.0% Higher Margin PVLA
Return on Equity (ROE) Capital Efficiency -321.2% -63.4% Higher ROE PVLA
52-Week Range Position Momentum 59% ($23โ€“$69) 68% ($72โ€“$180) Stronger Trend PVLA
Beta / 30D Volatility Risk Regime 1.39ฮฒ ยท 44% Vol 1.66ฮฒ ยท 75% Vol Lower Realized Risk TVTX
Unified Institutional Score Composite Signal 60.2 / 100 (BUY) 48.9 / 100 (HOLD) Higher Composite TVTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TVTX vs PVLA Buy Guide
TVTX CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live TVTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PVLA CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TVTX nor PVLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.